Articles Published in 2008

Clinsys Enters EDC Niche

Monday, December 8, 2008 06:00 AM

One company’s bad luck became another’s good fortune with Clinsys Clinical Research’s recent acquisition of a new electronic data capture (EDC) platform, TrialStat ClinicalAnalytics (TrialStat CA).

More... »

CenterWatch Monthly December 2008

Friday, December 5, 2008 11:15 AM

Demand for Medical Writing Continues to Rise

More... »

CROs Add New People, Positions

Thursday, December 4, 2008 11:33 AM

Although many companies are reducing headcount at an alarming rate, at least a few contract research organizations (CROs) continue to hire new people and create new positions. This week’s personnel news from around the clinical trial industry:

More... »

WuXi Cuts U.S. Manufacturing Business

Wednesday, December 3, 2008 11:17 AM

Chinese contract research organization (CRO) WuXi PharmaTech is discontinuing its U.S. biologics manufacturing operations as of December 31. As a result, the company will cut about 100 manufacturing and supporting positions at its Philadelphia facility.

More... »

GCT Increases Logistics Capabilities in Russia

Tuesday, December 2, 2008 06:00 AM

Global Clinical Trials (GCT), a contract research organization (CRO) serving Eastern Europe and Russia, has expanded its St. Petersburg drug storage facility, a move that will enhance the CRO’s ability to manage trial logistics in that region.

More... »

Quintiles Acquires Targeted Molecular Diagnostics

Monday, December 1, 2008 09:15 AM

Global contract research organization (CRO) Quintiles has acquired Westmont, Ill.-based Targeted Molecular Diagnostics (TMD), a specialty diagnostic laboratory focused on oncology.

More... »

Clinilabs Names Greenberg Director of Expanded Unit

Wednesday, November 26, 2008 06:00 AM

New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.

More... »

Parexel Expands Ethnobridging Capabilities

Tuesday, November 25, 2008 09:00 AM

Contract research organization (CRO) Parexel recently completed one of the first Chinese bridging studies to be conducted outside of China at the CRO’s Los Angeles facility. The study, conducted this spring, is one of a number of ethnobridging studies being pioneered by California Clinical Trials (CCT), which Parexel acquired two years ago.

More... »

SFDA, Big Pharma Share Concerns at Shanghai Conference

Monday, November 24, 2008 09:00 AM

In his regulatory keynote address at the China Trials 2008 conference in Shanghai, Dr. Yi Feng, director, Office of Review Management, Center for Drug Evaluation (CDE), State Food and Drug Administration (SFDA) gave a broad overview of the evolution of global clinical trials in China and pinpointed future trends and goals in the country.

More... »

Rural Population Key to China’s Clinical Research Market

Friday, November 21, 2008 11:37 AM

In his presentation at China Trials 2008 in Shanghai, “Conducting Global Post-Marketing Surveillance Studies in China—Opportunity and Practical Issues,” Mark Engel, president and chairman of Excel PharmaStudies, a large China-based contract research organization, identified two megatrends that will drive post-marketing surveillance studies to China: the rapid aging of its population and its increasingly insured rural population.

More... »